Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026)

Rani Therapeutics Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $21.0 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% year-over-year to $21.0 million in Q1 2026; TTM through Mar 2026 was $26.8 million, a 65.79% decrease from a year earlier, with the FY2025 full-year figure at $26.8 million, down 65.51% from the prior year.
• Change in Acquisitions & Divestments advanced to $21.0 million in Q1 2026 per RANI's latest filing, from $5.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $35.0 million in Q2 2023 and bottomed at $3.0 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $20.7 million (2024), against an average of $19.4 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 661.67% in 2023 and slumped 68.41% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $3.0 million in 2022, then soared by 661.67% to $22.8 million in 2023, then decreased by 11.16% to $20.3 million in 2024, then plunged by 71.67% to $5.8 million in 2025, then jumped by 265.22% to $21.0 million in 2026.
• Per Business Quant, the three latest RANI Change in Acquisitions & Divestments figures stand at $21.0 million (Q1 2026), $5.8 million (Q2 2025), and $21.0 million (Q1 2025).